On February 10, Xuntian Jiang, PhD and collaborators had their research titled, “AAV gene therapy for Tay-Sachs disease,” published in “Nature Medicine.” Tay-Sachs disease (TSD) is defined as an inherited neurological disorder caused by deficiency of hexosaminidase A. The study assesses two patients with infantile TSD in an adeno-associated virus (AAV) gene therapy expanded-access […]
Jiang publishes research on AAV gene therapy for Tay-Sachs disease
